Browsing Tag
XOMA Corporation
2 posts
Why did XOMA give shareholders two more weeks on the LAVA Therapeutics deal – and what happens next?
XOMA (NASDAQ: XOMA) extends its tender offer for LAVA Therapeutics (NASDAQ: LVTX) to Oct 17. Explore shareholder impact, CVR value, and deal prospects.
Kinnate Biopharma agrees to merger with XOMA, boosting shareholder value and advancing cancer research
Kinnate Biopharma Inc. (Nasdaq: KNTE), a leading clinical-stage precision oncology company, has announced a definitive merger agreement with…